Category: Parry
-
![Diagnos (ADK.V) uses AI and telemedicine to scan your eye for health issues in 16 countries]()
Diagnos (ADK.V) uses AI and telemedicine to scan your eye for health issues in 16 countries
In a world where companies toss the term ‘artificial intelligence’ around whenever the office intern figures out how to get a spreadsheet pie chart to update automatically, it’s nice to see a company utilizing actual AI and machine learning in a manner that involves actual intelligence and learning. Diagnos (ADK.V) is a health tech deal…
-
![As Australia opens to cannabis, Canntab’s (PILL.C) tech might just claim the box seat]()
As Australia opens to cannabis, Canntab’s (PILL.C) tech might just claim the box seat
News this week that Canntab Therapeutics (PILL.C) received an Australian patent for their hard-pressed cannabis pill tech, to match those received earlier in North America, didn’t launch the stock into space. That’s understandable, to be honest, as North American investors have taken an eye off the island continent and its slow roll to weed legalization…
-
Pure Extracts (PULL.C) looks to level up with dealers license application
At a time when many cannabis companies are enjoying bursts of investor interest, management at BC-based extractor Pure Extracts (PULL.C) must be getting frustrated as they roll out new contracts, new manufacturing lines, and advance in their pursuit of licensing that would allow them to break out into psychedelics. In essence, they’re hitting all the…
-
Interactive Games Technologies (BETS.C): The door is opening, and not just in North America
Adopting a sin as an acceptable, taxable business is slow going. From the moment our government overlords decide to un-ban a thing, it takes often years, even decades, to move through the many stages of evolution before it can become fully embraced by society. Take booze as an example. In the 1930’s, coming out of…
-
![Canntab Therapeutics (PILL.C) racks up revenue as CBD caplets shipped to Medipharm (LABS.T)]()
Canntab Therapeutics (PILL.C) racks up revenue as CBD caplets shipped to Medipharm (LABS.T)
Cannabis hard tablet IP holder Canntab Therapeutics (PILL.C) continues to send product to market, announcing Wednesday they’ve fulfilled 80% of their contract with Medipharm Labs (LABS.T), bringing in another half million dollars in revenue toward the $1.3 million deal announced last June. Orders under the agreement are a mix of Canntab’s proprietary instant release tablets…
-
Delic Holdings (DELC.C) acquires licensed psilocybin/cannabis lab, is doing legal shroom business
For a year, naysayers have dismissed the early stage shroom boom as being a pumpy bunch of pubco RTOs that won’t be able to do business legally for years. To be fair, there’s some basis to that dismissal. But only some. We’ve also been talking about how Delic Holdings (DELC.C) was an all-star team of…
-
Gold Mountain Mining (GMTN.V) is starting to bore me with all this effective management and kept promises
Do you ever get that feeling that you’ve written a story before? Weeks before and months before, and five times before and eight times before that? Whenever I see a Gold Mountain Mining (GMTN.V) news release come out, I get that sinking feeling in the base of my heart because I’ve got to do this…
-
Marvel Discovery (MARV.V) is a supermarket trolley full of early resource opportunities
Confused over whether you want to invest in gold explorers or battery metals? Wondering whether it’s time to get into nickel, copper, or cobalt? Do titanium, vanadium, and chromium enter your late night thoughts? Is it time for rare earths to make a run? Maybe the recent movement in uranium is your bag? If you’re…
-
![Organic Garage (OG.V) shifts from regional specialty grocer to plant-based foods player – and 10x’s]()
Organic Garage (OG.V) shifts from regional specialty grocer to plant-based foods player – and 10x’s
It’s no secret plant-based foods have been one of the real go-to investor categories of the rampaging North American stock market over the last year, especially since Beyond Meat (BYND.Q) went public in the US in late 2019 and went on an insane run, eventually settling in as a $10 billion company. It started a…
-
Canntab (PILL.C) yeets another patent for hard-pressed, long release cannabis pills
I’ve made no secret of the fact that the Canadian cannabis market frequently annoys the hell out of me. What I want is for it to be a mature space that more and more adults are making use of, and that is free to innovate, free to be excellent, free to market itself properly, and…
